Studying new antibiotics for multidrug resistant infections: are today's patients paying for unproved future benefits?

John H Powers, Scott R Evans,Aaron S Kesselheim

BMJ-BRITISH MEDICAL JOURNAL（2018）

引用 27|浏览6

暂无评分

摘要

Current approaches to testing new treatments for multidrug resistant bacterial diseases raise scientific and ethical issues for current and future patients, say John Powers and colleagues

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要